Mr Broek is founder and managing partner of HSMR Advisors, a US-based fund manager with an investment emphasis on small and mid-cap biotech public companies.
During his career Mr Broek has worked on both the buy and sell side of the funds management industry holding senior positions at Cooper Hill Partners, Hambrecht & Quist, Merrill Lynch and Oppenheimer & Co.
Alan Robertson, CEO of Pharmaxis, said: “Richard has been an engaged investor for a number of years and has great insight into the life science industry and the US capital markets. Our shareholders will benefit from his skills and experience.”